SCHEMBL4545232

SCHEMBL4545232

c1ccc(N(c2ccc(-c3cc4c5ccccc5c(-c5ccc(N(c6ccccc6)c6ccc7ccccc7c6)cc5)cc4c4ccccc34)cc2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MPI P34949 1/20 0.38
GSTP1 P09211 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
GPR84 Q9NQS5 2/20 0.35
ACMSD Q8TDX5 1/20 0.34
ACACA Q13085 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26054075 0.95 HPRT1 (0.41) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL25786213 0.95 GSTP1 (0.43) ALDH1A1KDM4EMAPTHPGDGSTP1
SCHEMBL17933153 0.94 MCL1 (0.37) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL22671846 0.92 CYP11B1 (0.41) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL26053436 0.91 HPRT1 (0.40) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL17933154 0.90 MCL1 (0.37) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL26054076 0.89 HPRT1 (0.36) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL24154049 0.89 CYP11B1 (0.41) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL8737540 0.89 CYP11B1 (0.42) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL9888990 0.89 HPRT1 (0.47) ALDH1A1KDM4EMAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178218-B2 Material for organic electroluminescent device and organic electroluminescent device using same IDEMITSU KOSAN CO., LTD. (JP) 2012-05-15 US disclosed
US-8178218-B2 Material for organic electroluminescent device and organic electroluminescent device using same IDEMITSU KOSAN CO., LTD. (JP) 2012-05-15 US disclosed
US-20090195149-A1 Material for organic electroluminescent device using same IDEMITSU KOSAN CO., LTD. (JP) 2009-08-06 US disclosed
US-20090195149-A1 Material for organic electroluminescent device using same IDEMITSU KOSAN CO., LTD. (JP) 2009-08-06 US disclosed
US-20070155991-A1 Material for organic electroluminescent device and organic electroluminescent device using same IDEMITSU KOSAN CO., LTD. (JP) 2007-07-05 US disclosed
US-20070155991-A1 Material for organic electroluminescent device and organic electroluminescent device using same IDEMITSU KOSAN CO., LTD. (JP) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090195149-A1 Material for organic electroluminescent device using same EML4, INCENP, EZH2 ALDH1A1 1147/4885KDM4E 325/4885MAPT 708/4885
US-20070155991-A1 Material for organic electroluminescent device and organic electroluminescent device using same CD99, EML4, L1CAM ALDH1A1 1095/4885KDM4E 504/4885MAPT 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.